Weight Control Meds May Influence Not Just How Much People Eat but What they Eat

Using supermarket purchase data, we found that individuals initiating GLP-1 RA treatment showed small but significant changes in their food purchases.

WeightControl.com Interview with:
Kathrine Kold Sørensen, postdoc, PhD, cand.scient.san.publ
Copenhagen University Hospital – Steno Diabetes Center Copenhagen
Department for Clinical and Translational Research
Denmark 

Kathrine Kold Sørensen, postdoc, PhD.

WeightControl.com:  What is the background for this study? 

Response: GLP-1 receptor agonists are widely used in the treatment of type 2 diabetes and obesity and are known to improve weight and metabolic outcomes. Beyond weight loss, however, the mechanisms underlying these benefits are not fully understood. Smaller studies and case reports have suggested that GLP-1 RAs may influence food preferences.